Merck registers Phase 3 sotatercept HFpEF trial; Terns completes two TERN-701 Phase 1 studiesSep 24Weekly roundup, 3 itemsMerck & Co., Inc.sotatercept-csrk
Merck posts Q2 loss on Terns charge, raises full-year sales outlookAug 4Quarterly updateMerck & Co., Inc.
Sign inSign in